Skip to main content
Log in

Recurrent thromboembolism as a hallmark of Cushing’s syndrome

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The present report describes a 54-year-old woman with a history of recurrent thromboembolic events. The clinical and physical examination led to suspect Cushing’s syndrome. Screening tests (urinary free Cortisol excretion and 1 mg dexamethasone) were inconclusive, but a detailed endocrine work up confirmed the presence of ACTH-dependent hypercortisolism. The patient was cured by the removal of a ACTH-secreting microadenoma by transsphenoidal route. The present case provides a clinical demonstration of a previous experimental evidence that a hypercoagulable state is present in Cushing’s syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sjoberg H.E., Blomback M., Granberg P.O. Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing’s syndrome. Acta Med. Scand. 199: 95, 1976.

    Article  PubMed  CAS  Google Scholar 

  2. Dal Bo Zanon R., Fornasiero L., Boscaro M., Cappellato G., Fabris F., Girolami A. Increased factor VIII associated activities in Cushing’s syndrome: a probable hypercoagulable state. Throm. Haemostas. 47: 116, 1982.

    Google Scholar 

  3. Patrassi G.M., Dal Bo Zanon R., Boscaro M., Martinelli S., Girolami A. Further studies on the hypercoagulable state of patients with Cushing’s syndrome. Thromb. Haemostas. 54: 518, 1985.

    CAS  Google Scholar 

  4. Blichert-Toft M., Bagerskov A., Lockwood K., Hasner E. Operative treatment, surgical approach, and related complications in 195 operations upon the adrenal glands. Surg. Gynecol. Obstet. 135: 261, 1972.

    PubMed  CAS  Google Scholar 

  5. Casonato A., Pontara E., Bertomoro A., Scarpa E., Sonino N., Girolami A. Abnormalities of primary haemostasis with consequent hypercoagulable state in patients with Cushing’s syndrome. J. Endocrinol. Invest. 18 (Suppl. no. 5): 75, 1995, abstract number 256.

    Google Scholar 

  6. Ikkala E., Myllyla G., Pelkonen R., Rasi V., Viinikka L., Ylikorkala O. Haemostatic parameters in Cushing’s syndrome. Acta Med. Scand. 217: 507, 1985.

    Article  PubMed  CAS  Google Scholar 

  7. Patrassi G.M., Sartori M.T., Viero M.L., Scarano L., Boscaro M., Girolami A. The fibrinolytic potential in patients with Cushing’s disease: a clue to their hypercoagulable state. Blood Coagul. Fibrinolysis 3: 789, 1992.

    Article  PubMed  CAS  Google Scholar 

  8. Simmons P.S., Miles J.M., Gerich J.E., Haymond M.W. Increased proteolysis. An effect of increased in plasma Cortisol within the physiological range. J. Clin. Invest. 73: 412, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Huges A., McVerry B.A., Wilkinson L., Goldstone A.H., Lewis D., Bloom A. Diabetes, a hypercoagulable state? Haemostatic variables in newly diagnosed type 2 diabetic patients. Acta Haematol. 69: 254, 1983.

    Article  Google Scholar 

  10. Boneu B., Durand D., Connilon F., Charlet J.P., Bierme R., Suc G.M. Increased level in factor VIII complex in severe arterial hypertension. Haemostasis 7: 332, 1978.

    PubMed  CAS  Google Scholar 

  11. Patrassi G.M., Fallo F., Martinelli S., Mantero F., Boeri G., Girolami A. The contact phase of blood coagulation and renin activation in essential hypertension before and after Captopril. Eur. Heart J. 5: 561, 1984.

    PubMed  CAS  Google Scholar 

  12. Jorgensen M., Bonnevie-Nielsen V. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis. Br. J. Haematol. 65: 175, 1987.

    Article  PubMed  CAS  Google Scholar 

  13. Engesser L., Brommer E.G.P., Kluft C., Briet E. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia. Thromb. Haemostas. 62: 673, 1989.

    CAS  Google Scholar 

  14. Patrassi G.M., Sartori M.T., Viero M., Boscaro M., Boeri G., Girolami A. Venous thrombosis and tissue plasminogen activator release deficiency: a family study. Blood Coagul. Fibrinol. 2: 231, 1991.

    Article  CAS  Google Scholar 

  15. Petaja J., Rasi V., Myllyla G., Vahtera E., Hallman H. Familial hypofibrinolysis and venous thrombosis. Br. J. Haematol. 71: 393, 1989.

    Article  PubMed  CAS  Google Scholar 

  16. Korninger C., Lechner K., Neissner H., Gossinger H., Kundi M. Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis. Thromb. Haemostas. 52: 127, 1984.

    CAS  Google Scholar 

  17. O’Connor N.T.J., Cederholm-Williams S.A., Fletcher E.W., Allington M., Sharp A.A. Significance of idiopathic deep venous thrombosis. Postgrad. Med. J. 60: 275, 1984.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Atkinson A.B., Kennedy A.L., Carson D.J., Hadden D.R., Weaver J.A., Sheridan B. Five cases of cyclical Cushing’s syndrome. Br. Med. J. 292: 1453, 1985.

    Article  Google Scholar 

  19. Schweikert H.U., Fehm H.L., Fahlbusch R., Martin R., Kolloch R., Higuchi M., Kruck F. Cyclic Cushing’s syndrome combined with Cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing’s syndrome. Acta Endocrinol. (Copenh.) 110: 289, 1985.

    CAS  Google Scholar 

  20. Sheeler L.R., Bay J.W. Normal overnight dexamethasone suppression tests (ODST) in patients with proven Cushing’s disease. In: Landolt A.M. et al. (Eds.), Advances in Pituitary Adenoma Reserch (Advances in the Biosciences, vol. 69). Pergamon Press, New York, 1988, p. 373.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

La Brocca, A., Terzolo, M., Pia, A. et al. Recurrent thromboembolism as a hallmark of Cushing’s syndrome. J Endocrinol Invest 20, 211–214 (1997). https://doi.org/10.1007/BF03346905

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346905

Key-words

Navigation